The Physician Payment Sunshine Act was meant to shed light on the financial relationship between drugmakers, biotech, and medical device companies whether those payments be for general or research purposes.
The Centers for Medicare and Medicaid Services has recorded these payments now for two complete years in a row with partial data available for 2013.
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
The infographic below, created by MedCity News, based on data from CMS’s Open Payments website and Modern Healthcare shows the companies that spent the most money in 2015 in comparison with the amount they spent the year before and overall payments.
Photo: Flickr user Pictures of Money
